These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38958557)

  • 1. Time-encoded ASL reveals lower cerebral blood flow in the early AD continuum.
    Falcon C; Montesinos P; Václavů L; Kassinopoulos M; Minguillon C; Fauria K; Cascales-Lahoz D; Contador J; Fernández-Lebrero A; Navalpotro I; Puig-Pijoan A; Grau-Rivera O; Kollmorgen G; Quijano-Rubio C; Molinuevo JL; Zetterberg H; Blennow K; Suárez-Calvet M; Van Osch MJP; Sanchez-Gonzalez J; Gispert JD
    Alzheimers Dement; 2024 Aug; 20(8):5183-5197. PubMed ID: 38958557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
    Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classifying cognitive impairment based on the spatial heterogeneity of cerebral blood flow images.
    Shirzadi Z; Stefanovic B; Mutsaerts HJMM; Masellis M; MacIntosh BJ;
    J Magn Reson Imaging; 2019 Sep; 50(3):858-867. PubMed ID: 30666734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray matter hypoperfusion is a late pathological event in the course of Alzheimer's disease.
    Ahmadi K; Pereira JB; Berron D; Vogel J; Ingala S; Strandberg OT; Janelidze S; Barkhof F; Pfeuffer J; Knutsson L; van Westen D; Palmqvist S; Mutsaerts HJ; Hansson O
    J Cereb Blood Flow Metab; 2023 Apr; 43(4):565-580. PubMed ID: 36412244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults.
    Bangen KJ; Clark AL; Edmonds EC; Evangelista ND; Werhane ML; Thomas KR; Locano LE; Tran M; Zlatar ZZ; Nation DA; Bondi MW; Delano-Wood L
    Front Aging Neurosci; 2017; 9():181. PubMed ID: 28642699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Diagnostic Applications of Multi-Delay Arterial Spin Labeling in Early Alzheimer's Disease: The Chinese Imaging, Biomarkers, and Lifestyle Study.
    Sun M; Wang YL; Li R; Jiang J; Zhang Y; Li W; Zhang Y; Jia Z; Chappell M; Xu J
    Front Neurosci; 2022; 16():934471. PubMed ID: 35937865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer's continuum.
    Rubinski A; Tosun D; Franzmeier N; Neitzel J; Frontzkowski L; Weiner M; Ewers M
    Neurobiol Aging; 2021 Jun; 102():111-118. PubMed ID: 33765424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral perfusion in the predementia stages of Alzheimer's disease.
    Binnewijzend MA; Benedictus MR; Kuijer JP; van der Flier WM; Teunissen CE; Prins ND; Wattjes MP; van Berckel BN; Scheltens P; Barkhof F
    Eur Radiol; 2016 Feb; 26(2):506-14. PubMed ID: 26040647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Intraindividual Cognitive Variability Is Associated With Reduction in Regional Cerebral Blood Flow Among Alzheimer's Disease Biomarker-Positive Older Adults.
    Holmqvist SL; Thomas KR; Brenner EK; Edmonds EC; Calcetas A; Edwards L; Bordyug M; Bangen KJ
    Front Aging Neurosci; 2022; 14():859873. PubMed ID: 35875798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.
    Wierenga CE; Hays CC; Zlatar ZZ
    J Alzheimers Dis; 2014; 42 Suppl 4(Suppl 4):S411-9. PubMed ID: 25159672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral blood flow, tau imaging, and memory associations in cognitively unimpaired older adults.
    Weigand AJ; Hamlin AM; Breton J; Clark AL
    Cereb Circ Cogn Behav; 2022; 3():100153. PubMed ID: 36353072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different post label delay cerebral blood flow measurements in patients with Alzheimer's disease using 3D arterial spin labeling.
    Liu Y; Zeng X; Wang Z; Zhang N; Fan D; Yuan H
    Magn Reson Imaging; 2015 Nov; 33(9):1019-1025. PubMed ID: 26113261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer's disease.
    Fazlollahi A; Calamante F; Liang X; Bourgeat P; Raniga P; Dore V; Fripp J; Ames D; Masters CL; Rowe CC; Connelly A; Villemagne VL; Salvado O;
    J Magn Reson Imaging; 2020 Feb; 51(2):505-513. PubMed ID: 31145515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoupling of Regional Cerebral Blood Flow and Brain Function Along the Alzheimer's Disease Continuum.
    Li J; Zeng Q; Luo X; Li K; Liu X; Hong L; Zhang X; Zhong S; Qiu T; Liu Z; Chen Y; Huang P; Zhang M;
    J Alzheimers Dis; 2023; 95(1):287-298. PubMed ID: 37483006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypo- and hyper-perfusion in MCI and AD identified by different ASL MRI sequences.
    Camargo A; Wang Z;
    Brain Imaging Behav; 2023 Jun; 17(3):306-319. PubMed ID: 36973476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.
    Camargo A; Wang Z;
    J Alzheimers Dis; 2021; 81(4):1727-1735. PubMed ID: 33967053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrovascular reactivity measurements using simultaneous
    Zhao MY; Fan AP; Chen DY; Sokolska MJ; Guo J; Ishii Y; Shin DD; Khalighi MM; Holley D; Halbert K; Otte A; Williams B; Rostami T; Park JH; Shen B; Zaharchuk G
    Neuroimage; 2021 Jun; 233():117955. PubMed ID: 33716155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
    Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
    JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
    Benedet AL; Milà-Alomà M; Vrillon A; Ashton NJ; Pascoal TA; Lussier F; Karikari TK; Hourregue C; Cognat E; Dumurgier J; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Salvadó G; Shekari M; Operto G; Gispert JD; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Zimmer ER; Zetterberg H; Molinuevo JL; Paquet C; Rosa-Neto P; Blennow K; Suárez-Calvet M;
    JAMA Neurol; 2021 Dec; 78(12):1471-1483. PubMed ID: 34661615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.